Bristol OTC Stock Buy Hold or Sell Recommendation

BMYMP -  USA Stock  

USD 1,419  313.22  28.32%

Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Bristol Myer Squi is 'Strong Hold'. Macroaxis provides Bristol Myer buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BMYMP positions. The advice algorithm takes into account all of Bristol Myer's available fundamental, technical, and predictive indicators you will find on this site.

Bristol Advice 

 
Refresh
The advice is provided from Bristol Myer's buy-and-hold perspective. Continue to Bristol Myer Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Bristol and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Bristol Myer Squi.

Execute Bristol Myer Buy or Sell Advice

The Bristol recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Bristol Myer Squi. Macroaxis does not own or have any residual interests in Bristol Myer Squi or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Bristol Myer's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Bristol MyerBuy Bristol Myer
Strong Hold

Volatility

Very steadyDetails

Hype Condition

StaleDetails

Current Valuation

Fairly ValuedDetails

Odds of Distress

Close to AverageDetails

Economic Sensitivity

Almost mirrors the marketDetails

Analyst Consensus

Not AvailableDetails

Reporting Quality (M-Score)

UnavailableDetails
For the selected time horizon Bristol Myer Squi has a Risk Adjusted Performance of 0.0911, Jensen Alpha of 1.83, Total Risk Alpha of 3.38 and Treynor Ratio of 1.84
Macroaxis provides advice on Bristol Myer Squi to complement and cross-verify current analyst consensus on Bristol Myer Squi. Our investment recommendation engine determines the company's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. To make sure Bristol Myer is not overpriced, please confirm all Bristol Myer Squi fundamentals, including its cash per share, and the relationship between the revenue and cash flow from operations . Given that Bristol Myer Squi has a price to book of 117.91 X, we suggest you to validate Bristol Myer Squi market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Bristol Myer Trading Alerts and Improvement Suggestions

Bristol Myer Returns Distribution Density

The distribution of Bristol Myer's historical returns is an attempt to chart the future uncertainty of Bristol Myer's future price movements. The chart of the probability distribution of Bristol Myer stock daily returns describes the distribution of returns around its average expected value. We use Bristol Myer Squi price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Bristol Myer returns is essential to provide solid investment advice for Bristol Myer stock.
Mean Return1.76Value At Risk-7.36
Potential Upside28.32Standard Deviation17.89
 Return Density 
      Distribution 
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Bristol Myer historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Bristol Myer Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Bristol Myer or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Bristol Myer stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Bristol stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over DOW
1.83
β
Beta against DOW0.95
σ
Overall volatility
18.58
Ir
Information ratio 0.10

Bristol Myer Volatility Alert

Bristol Myer Squi is displaying above-average volatility over the selected time horizon. Investors should scrutinize Bristol Myer Squi independently to ensure intended market timing strategies are aligned with expectations about Bristol Myer volatility. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Bristol Myer's otc stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Bristol Myer's otc stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Bristol Myer Implied Volatility

Bristol Myer's implied volatility exposes the market's sentiment of Bristol Myer Squi stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Bristol Myer's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Bristol Myer stock will not fluctuate a lot when Bristol Myer's options are near their expiration.

Bristol Myer Fundamentals Vs Peers

Comparing Bristol Myer's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Bristol Myer's direct or indirect competition across all of the common fundamentals between Bristol Myer and the related equities. This way, we can detect undervalued stocks with similar characteristics as Bristol Myer or determine the otc stocks which would be an excellent addition to an existing portfolio. Peer analysis of Bristol Myer's fundamental indicators could also be used in its relative valuation, which is a method of valuing Bristol Myer by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Bristol Myer to competition
FundamentalsBristol MyerPeer Average
Return On Equity2.97 %(0.31) %
Return On Asset10.68 %(0.14) %
Profit Margin1.74 %(1.27) %
Operating Margin26.12 %(5.51) %
Shares Outstanding1.64 B571.82 M
Number of Shares Shorted104.71 M
Price to Book117.91 X9.51 X
Price to Sales67.57 X11.42 X
Revenue21.6 B9.43 B
Gross Profit14.71 B27.38 B
EBITDA5.97 B3.9 B
Net Income376 M570.98 M
Cash and Equivalents6.07 B2.7 B
Cash per Share3.72 X5.01 X
Total Debt7.39 B5.32 B
Debt to Equity59.40 %48.70 %
Current Ratio1.40 X2.16 X
Book Value Per Share7.55 X1.93 K
Cash Flow from Operations5.06 B971.22 M
Short Ratio0.59 X4.00 X
Earnings Per Share0.22 X3.12 X
Number of Employees23.7 K18.84 K
Beta0.35-0.15
Market Capitalization2330 B19.03 B
Last Dividend Paid0.5

About Bristol Myer Buy or Sell Advice

When is the right time to buy or sell Bristol Myer Squi? Buying financial instruments such as Bristol OTC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Although Bristol Myer investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Bristol Myer in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Banks Thematic Idea Now

Banks
Banks Theme
Large and small money and credit banks and credit services. Banks theme has 30 constituents.
View All  Next Launch Banks
Continue to Bristol Myer Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Bristol Myer Squi information on this page should be used as a complementary analysis to other Bristol Myer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Complementary Tools for Bristol OTC Stock analysis

When running Bristol Myer Squi price analysis, check to measure Bristol Myer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myer is operating at the current time. Most of Bristol Myer's value examination focuses on studying past and present price action to predict the probability of Bristol Myer's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bristol Myer's price. Additionally, you may evaluate how the addition of Bristol Myer to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Is Bristol Myer's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bristol Myer. If investors know Bristol will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bristol Myer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Bristol Myer Squi is measured differently than its book value, which is the value of Bristol that is recorded on the company's balance sheet. Investors also form their own opinion of Bristol Myer's value that differs from its market value or its book value, called intrinsic value, which is Bristol Myer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bristol Myer's market value can be influenced by many factors that don't directly affect Bristol Myer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bristol Myer's value and its price as these two are different measures arrived at by different means. Investors typically determine Bristol Myer value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bristol Myer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.